The NIDA Medications Development Database now has over 100 subscribers, including some universities and pharmaceutical companies in Western Europe. The database represents a resource for researchers working in the area of drug abuse and neuroscience. It is a tool which allows researchers to study relationships between structure and activity in the search for new and improved compounds to be targeted as treatment medications. The database now contains nearly 6,000 compounds and biological data consisting of receptor binding data and drug discrimination and self-administration studies, as well as toxicology. All data is preclinical.
Individual training is also available at no cost to the user.
This program announcement is critical because prevention efforts must be developed to sustain the changed behaviors over time and prevent relapse. The announcement emphasizes studies on the addictive properties of nicotine. Applications are due in June and funding of projects is expected by September.